Therapeutic Administration of a Monoclonal Anti-Il-1β Antibody Protects Against Experimental Melioidosis.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 27219859)

Published in Shock on November 01, 2016

Authors

Tassili A F Weehuizen1, Jacqueline M Lankelma, Hanna K De Jong, Onno J De Boer, Joris J T H Roelofs, Nicholas P Day, Hermann Gram, Alex F De Vos, W Joost Wiersinga

Author Affiliations

1: *Center for Infection and Immunity Amsterdam (CINIMA)/Center for Experimental and Molecular Medicine (CEMM), Academic Medical Center, Amsterdam, The Netherlands †Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands ‡Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand §Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK ||Novartis Institutes for BioMedical Research, Basel, Switzerland ¶Department of Internal medicine, Division of Infectious Diseases, Academic Medical Center, Amsterdam, The Netherlands.

Articles cited by this

The inflammasomes. Cell (2010) 19.37

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58

Melioidosis. N Engl J Med (2012) 6.94

Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol (2010) 6.05

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med (1997) 4.86

Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol (2012) 4.72

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature (1990) 4.46

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol (2013) 4.38

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78

The inflammasome: an integrated view. Immunol Rev (2011) 3.52

The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17

Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J Immunol (2010) 2.88

Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun (1999) 2.41

Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity (2011) 2.19

Effect of endotoxin in IL-1 beta-deficient mice. J Immunol (1996) 1.92

Treating inflammation by blocking interleukin-1 in humans. Semin Immunol (2013) 1.75

Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med (2014) 1.68

Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog (2011) 1.68

Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis. Future Microbiol (2012) 1.52

Inflammasome mRNA expression in human monocytes during early septic shock. Am J Respir Crit Care Med (2008) 1.52

Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis. J Infect Dis (1999) 1.51

Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol (2016) 1.51

Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis (2011) 1.45

Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine (2008) 1.43

Role of the inflammasome, IL-1β, and IL-18 in bacterial infections. ScientificWorldJournal (2011) 1.15

Differential splicing of the apoptosis-associated speck like protein containing a caspase recruitment domain (ASC) regulates inflammasomes. J Inflamm (Lond) (2010) 1.14

Inflammasome-independent regulation of IL-1-family cytokines. Annu Rev Immunol (2014) 1.11

Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun (2007) 1.07

High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei. Infect Immun (2007) 1.07

Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10. J Immunol (2004) 0.99

Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I. APMIS (2010) 0.87

Associations between interleukin-1 gene polymorphisms and sepsis risk: a meta-analysis. BMC Med Genet (2014) 0.85

Glyburide reduces bacterial dissemination in a mouse model of melioidosis. PLoS Negl Trop Dis (2013) 0.84

NLRC4 and TLR5 each contribute to host defense in respiratory melioidosis. PLoS Negl Trop Dis (2014) 0.80

Articles by these authors

Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med (2014) 11.87

Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell (2005) 9.01

Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol (2006) 6.34

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet (2013) 5.22

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet (2007) 4.23

MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha. Science (2002) 3.78

Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J Bacteriol (2006) 3.37

CISH and susceptibility to infectious diseases. N Engl J Med (2010) 3.31

MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 2.87

Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol (2005) 2.26

A systematic overview of published antimalarial drug trials. Trans R Soc Trop Med Hyg (2004) 2.02

Induced hypothermia is protective in a rat model of pneumococcal pneumonia associated with increased adenosine triphosphate availability and turnover*. Crit Care Med (2012) 2.02

Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol (2014) 2.02

Relative contributions of macrovascular and microvascular dysfunction to disease severity in falciparum malaria. J Infect Dis (2012) 1.99

Mechanical ventilation using non-injurious ventilation settings causes lung injury in the absence of pre-existing lung injury in healthy mice. Crit Care (2009) 1.92

Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One (2012) 1.90

IRAK-4 kinase activity-dependent and -independent regulation of lipopolysaccharide-inducible genes. Eur J Immunol (2008) 1.83

Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81

Meticillin-resistant Staphylococcus aureus in rural Asia. Lancet Infect Dis (2006) 1.80

Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg (2006) 1.65

Axonal injury in cerebral malaria. Am J Pathol (2002) 1.65

Association of high Orientia tsutsugamushi DNA loads with disease of greater severity in adults with scrub typhus. J Clin Microbiol (2008) 1.64

Acute phase response impairs host defense against Pseudomonas aeruginosa pneumonia in mice. Crit Care Med (2008) 1.64

Unresolved problems related to scrub typhus: a seriously neglected life-threatening disease. Am J Trop Med Hyg (2013) 1.64

Rapid diagnosis of scrub typhus in rural Thailand using polymerase chain reaction. Am J Trop Med Hyg (2006) 1.63

Melioidosis in 6 tsunami survivors in southern Thailand. Clin Infect Dis (2005) 1.62

The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther (2008) 1.60

Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats. Crit Care Med (2008) 1.58

Genetic diversity and microevolution of Burkholderia pseudomallei in the environment. PLoS Negl Trop Dis (2008) 1.58

Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med (2007) 1.58

Host-pathogen interaction in invasive Salmonellosis. PLoS Pathog (2012) 1.57

In the critically ill patient, diabetes predicts mortality independent of statin therapy but is not associated with acute lung injury: a cohort study. Crit Care Med (2012) 1.53

The critical role of kinase activity of interleukin-1 receptor-associated kinase 4 in animal models of joint inflammation. Arthritis Rheum (2009) 1.52

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis. Arthritis Rheum (2006) 1.50

Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis (2012) 1.48

A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. PLoS One (2012) 1.47

Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis (2005) 1.47

Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis. Clin Infect Dis (2011) 1.45

Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc (2008) 1.45

A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. Cell Host Microbe (2011) 1.44

Overexpression of activated protein C is detrimental during severe experimental gram-negative sepsis (melioidosis). Crit Care Med (2013) 1.43

Endogenous tissue-type plasminogen activator impairs host defense during severe experimental Gram-negative sepsis (melioidosis)*. Crit Care Med (2012) 1.41

Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border. PLoS Negl Trop Dis (2010) 1.39

Molecular detection and speciation of pathogenic Leptospira spp. in blood from patients with culture-negative leptospirosis. BMC Infect Dis (2011) 1.39

MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei. PLoS One (2008) 1.33

Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One (2009) 1.32

Emergence of pediatric melioidosis in Siem Reap, Cambodia. Am J Trop Med Hyg (2010) 1.32

Burkholderia pseudomallei antibodies in children, Cambodia. Emerg Infect Dis (2008) 1.31

Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect Immun (2005) 1.30

Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol (2006) 1.29

Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country. PLoS One (2009) 1.29

Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei. Proc Natl Acad Sci U S A (2011) 1.29

Clinical diagnosis and geographic distribution of leptospirosis, Thailand. Emerg Infect Dis (2007) 1.29

The acute-phase response and serum amyloid A inhibit the inflammatory response to Acinetobacter baumannii Pneumonia. J Infect Dis (2005) 1.28

Community engagement on the Thai-Burmese border: rationale, experience and lessons learnt. Int Health (2010) 1.28

Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci (2009) 1.27

The microscopic agglutination test (MAT) is an unreliable predictor of infecting Leptospira serovar in Thailand. Am J Trop Med Hyg (2009) 1.26

Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis (2009) 1.26

Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol (2013) 1.25

Quantitation of B. Pseudomallei in clinical samples. Am J Trop Med Hyg (2007) 1.23

Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis (2008) 1.22

Inflammation patterns induced by different Burkholderia species in mice. Cell Microbiol (2007) 1.22

Plasminogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood (2006) 1.21

Ventilator-induced lung injury is mediated by the NLRP3 inflammasome. Anesthesiology (2012) 1.21

IRAK-4 kinase activity is required for interleukin-1 (IL-1) receptor- and toll-like receptor 7-mediated signaling and gene expression. J Biol Chem (2007) 1.19

Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis). Crit Care Med (2009) 1.18

Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother (2009) 1.17

A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Negl Trop Dis (2013) 1.17

TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J Immunol (2008) 1.16

Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice. J Immunol (2005) 1.16

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15

Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur J Neurosci (2011) 1.14

Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn (2010) 1.13

PTPN22 and invasive bacterial disease. Nat Genet (2006) 1.12

IkappaB genetic polymorphisms and invasive pneumococcal disease. Am J Respir Crit Care Med (2007) 1.11

Enterococcal surface protein transiently aggravates Enterococcus faecium-induced urinary tract infection in mice. J Infect Dis (2009) 1.11

Protection against renal ischemia reperfusion injury by CD44 disruption. J Am Soc Nephrol (2005) 1.10

Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. Evol Appl (2009) 1.09

CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol (2004) 1.08

Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun (2007) 1.07

Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. Blood (2010) 1.07

High-throughput mRNA profiling characterizes the expression of inflammatory molecules in sepsis caused by Burkholderia pseudomallei. Infect Immun (2007) 1.07

Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol (2013) 1.05

Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance. Mol Cell Biol (2008) 1.05

Short report: Melioidosis in Myanmar: forgotten but not gone? Am J Trop Med Hyg (2006) 1.04

Lipopolysaccharide inhibits Th2 lung inflammation induced by house dust mite allergens in mice. Am J Respir Cell Mol Biol (2012) 1.04

The clinical significance of cerebrospinal fluid levels of kynurenine pathway metabolites and lactate in severe malaria. J Infect Dis (2002) 1.03

Variable presentation of neurological melioidosis in Northeast Thailand. Am J Trop Med Hyg (2007) 1.02

Neutrophils are essential for rapid clearance of Enterococcus faecium in mice. Infect Immun (2008) 1.01

SAR of benzoylpyridines and benzophenones as p38alpha MAP kinase inhibitors with oral activity. Bioorg Med Chem Lett (2004) 1.01

Accuracy of a commercial IgM ELISA for the diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg (2012) 1.00

MNK1 and MNK2 regulation in HER2-overexpressing breast cancer lines. J Biol Chem (2006) 1.00

Accuracy of loop-mediated isothermal amplification for diagnosis of human leptospirosis in Thailand. Am J Trop Med Hyg (2011) 1.00

Emergence of community-associated methicillin-resistant Staphylococcus aureus carriage in children in Cambodia. Am J Trop Med Hyg (2011) 1.00

Effects of malaria heme products on red blood cell deformability. Am J Trop Med Hyg (2007) 0.98

Recombinant human soluble tumor necrosis factor-alpha receptor fusion protein partly attenuates ventilator-induced lung injury. Shock (2009) 0.97

Endogenous tissue-type plasminogen activator is protective during Escherichia coli-induced abdominal sepsis in mice. J Immunol (2006) 0.96

Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis. J Immunol (2010) 0.96